Page last updated: 2024-10-30

mechlorethamine and Immunoblastic Lymphadenopathy

mechlorethamine has been researched along with Immunoblastic Lymphadenopathy in 3 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lazza, M1
Ramella, G1
Cianferoni, MF1
Rognoni, M1
Bevilacqua, M1
Cazzola, M1
Bergamaschi, G1
Castello, A1
Del Forno, C1
Dezza, L1
Magrini, U1
Ascari, E1
Ganesan, TS1
Dhaliwal, HS1
Dorreen, MS1
Stansfeld, AG1
Habeshaw, JA1
Lister, TA1

Other Studies

3 other studies available for mechlorethamine and Immunoblastic Lymphadenopathy

ArticleYear
[A case of angioimmunoblastic lymphadenopathy with dysproteinemia].
    Minerva medica, 1982, Nov-10, Volume: 73, Issue:43

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Protein Disorders; Child; Humans; Immunoblasti

1982
Kaposi's sarcoma complicating immunosuppressive therapy for angioimmunoblastic lymphadenopathy with dysproteinemia.
    Tumori, 1982, Dec-31, Volume: 68, Issue:6

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combinati

1982
Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study.
    British journal of cancer, 1987, Volume: 55, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Female; Humans

1987